Type 2 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 2 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-03-18Clinical Trial Update: Walnut Consumption, Endothelial Function, and Biomarkers [NA]
A completed clinical trial investigated the impact of walnut consumption on endothelial function and biomarkers in individuals with coronary…
-
FDA approval · 2016-03-17FDA Approved: INVOKAMET — Supplemental Application (Janssen Pharmaceuticals, Inc.)
FDA approved a supplemental application for INVOKAMET (canagliflozin and metformin hydrochloride) from Janssen Pharmaceuticals, Inc.
-
FDA approval · 2016-03-17FDA Approved: ALOGLIPTIN AND PIOGLITAZONE — Supplemental Application (Padagis Israel Pharmaceuticals Ltd)
The FDA approved a supplemental application for a fixed-dose combination of alogliptin benzoate and pioglitazone hydrochloride to treat type…
-
CLINICAL_TRIALS trial_result · 2016-03-17Clinical Trial Update: Safety and Efficacy of Saxagliptin in Triple Therapy to Treat Subjects With Type 2 Diabetes [Phase 3]
Clinical Trial Update reports Phase 3 results on the safety and efficacy of saxagliptin in triple therapy for subjects with type 2 diabetes.…
-
CLINICAL_TRIALS trial_result · 2016-03-17Clinical Trial Update: Phase IV Study With a 36-week Extension Period to Evaluate the Efficacy and Safety of Dapagliflozin Therapy When Added to the Therapy of Japanese Patients With Type 2 Diabetes With Inadequate Glycemic Control on Insulin. [Phase 4]
Phase IV study evaluating the efficacy and safety of adding dapagliflozin to insulin therapy in Japanese patients with Type 2 Diabetes Melli…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-03-17Clinical Trial Update: A Trial Investigating the Efficacy and Safety of Flexible vs. Fixed Dosing and Simple vs. Stepwise Titration With Once Daily (OD) Insulin Degludec in Inadequately Treated Subjects With Type 2 Diabetes [Phase 3]
Phase 3 trial evaluating flexible versus fixed dosing and simple versus stepwise titration of once-daily insulin degludec in adults with ina…
-
CLINICAL_TRIALS trial_result · 2016-03-16Clinical Trial Update: Efficacy Study of the DIAMOND System to Treat Type 2 Diabetes Mellitus [NA]
This clinical trial update notes the completion of an efficacy study evaluating the DIAMOND System for treating Type 2 Diabetes Mellitus.
-
CLINICAL_TRIALS trial_result · 2016-03-16Clinical Trial Update: Impact of n-3 Polyunsaturated Fatty Acids in a Protein-enriched Diet With Low GI in Type 2 Diabetes Patients
A completed clinical trial evaluated the impact of omega-3 polyunsaturated fatty acids added to a protein-enriched, low-glycemic diet in adu…
-
CLINICAL_TRIALS trial_result · 2016-03-16Clinical Trial Update: VA HDL Intervention Trial (VA-HIT) Ancillary Study Data Analysis
This document provides an ancillary data analysis from the VA-HIT trial evaluating HDL-focused therapy in men with coronary artery disease a…
-
CLINICAL_TRIALS trial_result · 2016-03-16Clinical Trial Update: SIT LESS 2: Effect of Sitting Less on Glucose Regulation in People With Diabetes Mellitus Type 2 [NA]
A completed clinical trial evaluating whether reducing daily sitting time improves glucose regulation in adults with type 2 diabetes.
-
CLINICAL_TRIALS trial_result · 2016-03-16Clinical Trial Update: The DIAMOND® for the Treatment of Type 2 Diabetes [NA]
A clinical trial update for the DIAMOND program evaluating a treatment for Type 2 Diabetes; the current phase and status are not provided (s…
-
CLINICAL_TRIALS trial_result · 2016-03-15Clinical Trial Update: A Phase 1 Study In Japanese Subjects With Type 2 Diabetes Mellitus As Monotherapy [Phase 1]
Pfizer conducted a Phase 1 monotherapy trial in Japanese subjects with Type 2 Diabetes Mellitus; results were posted in 2016.
-
CLINICAL_TRIALS trial_result · 2016-03-15Clinical Trial Update: OpT2mise Glucose Control in Type 2 Diabetes Mellitus (DM) With Insulin Pump Therapy [NA]
A completed clinical trial evaluated OpT2mise glucose control in Type 2 diabetes mellitus using insulin pump therapy; results were posted in…
-
CLINICAL_TRIALS safety_alert · 2016-03-14Clinical Trial Update: Incretin-based Drugs and Pancreatic Cancer
A completed observational study assessing whether incretin-based therapies for type 2 diabetes are linked to pancreatic cancer, highlighting…
-
CLINICAL_TRIALS safety_alert · 2016-03-14Clinical Trial Update: High Potency Statins and the Risk of Diabetes
A clinical trial update discusses the potential association between high-potency statins and an increased risk of developing Type 2 diabetes…
-
CLINICAL_TRIALS trial_result · 2016-03-14Clinical Trial Update: Variation of Glucose Values at Early Stages of Diabetes - Continuous Glucose Monitoring
The document reports the completion of a clinical trial studying variations in glucose values at early stages of type 2 diabetes using conti…
-
CLINICAL_TRIALS trial_result · 2016-03-11Clinical Trial Update: Implementation of A Patient Centered Self-Management Program for Patients With Type 2 Diabetes [NA]
This document reports the completion of a clinical trial evaluating a patient-centered self-management program for individuals with Type 2 d…
-
EMA withdrawal · 2016-03-10EMA Lapsed: Paglitaz (pioglitazone hydrochloride) — Krka, d.d., Novo mesto
The EMA indicates that Paglitaz (pioglitazone hydrochloride) by Krka has lapsed, with Type 2 diabetes mellitus as the therapeutic area.
-
CLINICAL_TRIALS trial_result · 2016-03-10Clinical Trial Update: Mobile Sipoo - Telemonitoring With Combined With Active Assistance Technology [NA]
Update on a completed clinical trial evaluating a telemonitoring system with active assistance technology for patients with type 2 diabetes …
-
CLINICAL_TRIALS trial_result · 2016-03-08Clinical Trial Update: Effects of Resveratrol on Inflammation in Type 2 Diabetic Patients [Phase 3]
A Phase 3 trial evaluating resveratrol's impact on inflammation in patients with Type 2 Diabetes Mellitus has completed.
-
CLINICAL_TRIALS trial_result · 2016-03-08Clinical Trial Update: Diabetes and Cardiovascular Risk In Mexico City (San Antonio Heart Study)
This clinical trial update reports the completion of the San Antonio Heart Study evaluating diabetes mellitus type 2 and cardiovascular risk…
-
CLINICAL_TRIALS trial_result · 2016-03-08Clinical Trial Update: Incidence of Diabetes and Cardiovascular Disease in Mexican Americans
The clinical trial update summarizes the incidence of diabetes and cardiovascular disease in Mexican Americans and notes the study status as…
-
CLINICAL_TRIALS research · 2016-03-08Clinical Trial Update: ALA on Glycemic Control in T2DM Participants
This document provides an update on a clinical trial evaluating the effects of alpha-lipoic acid (ALA) on glycemic control in participants w…
-
CLINICAL_TRIALS trial_result · 2016-03-07Clinical Trial Update: A Study of Dulaglutide in Chinese Participants [Phase 1]
Phase 1 trial of dulaglutide in Chinese participants completed, with results posted in 2016.
-
CLINICAL_TRIALS trial_result · 2016-03-07Clinical Trial Update: Prandial Orientated Biphasic Insulin Aspart 30 Therapy - the Physiological Premix Insulin Therapy for Type 2 Diabetes
This update summarizes a completed clinical trial evaluating prandial-oriented biphasic insulin aspart 30 as a premixed insulin therapy for …